. Author manuscript; available in PMC: 2012 Apr 16.

Published in final edited form as: Cancer Res. 2011 Aug 15;71(19):6240–6249. doi: 10.1158/0008-5472.CAN-11-1266

Table 1.

Subjects by country and genotyping platform (iPLEX, GWAS)

Country	No. of studies	Age range (mean)^a		Years of diagnosis^a	iPLEX			GWAS			Combined
Country	No. of studies	Cases	Controls	Years of diagnosis^a	Cases	Controls	Total	Cases	Controls	Total	Cases	Controls	Total
U.S.A	5	25 - 92 (52)	24 - 92 (62)	1990 - 2010	711	448	1159	35	1126	1161	746	1574	2320
Australia	3	25 - 91 (56)	29 - 72 (46)	1990 - 2009	186	59	245	21	657	678	207	716	923
U.K.	5	22 - 93 (45)	42 - 81 (53)	1971 - 2010	573	111	684	6	1374	1380	579	1485	2064
Finland	3	27 - 90 (55)	18 - 80 (57)	1990 - 2004	101	88	189	85	221	306	186	309	495
Germany	6	22 - 88 (57)	24 - 81 (58)	1993 - 2008	740	501	1241	126	215	341	866	716	1582
Greece	1	21 - 79 (53)	34 - 82 (50)	1997 - 2010	273	85	358	0	0	0	273	85	358
Netherlands	1	26 - 62 (39)	NA	1995 - 2007	67	0	67	0	0	0	67	0	67
Sweden	1	48 - 88 (62)	48 - 85 (62)	1998 - 2000	27	26	53	0	0	0	27	26	53
Total	25	21 - 93 (52)	18 - 92 (56)	1971 - 2010	2707	1385	4092	273	3593	3866	2980	4978	7958

Study-specific distributions shown in Supplementary Table 1